News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
180,344 Results
Type
Article (32188)
Company Profile (10)
Press Release (147811)
Multimedia
Podcasts (10)
Webinars (10)
Section
Business (54778)
Career Advice (364)
Deals (3237)
Drug Delivery (11)
Drug Development (24130)
Employer Resources (32)
FDA (3394)
Job Trends (3217)
News (80926)
Policy (4232)
Tag
2027 Pharm Country Standard (1)
Academia (2448)
Academic (1)
Accelerated approval (16)
ADA (12)
Adcomms (9)
Allergies (54)
Alliances (10918)
ALS (73)
Alzheimer's disease (676)
Antibody-drug conjugate (ADC) (91)
Approvals (3600)
Artificial intelligence (172)
ASCO (115)
Autoimmune disease (70)
Automation (13)
Bankruptcy (18)
Best Places to Work (2687)
BIO (7)
BIOSECURE Act (3)
Biosimilars (18)
BioSpace Insights (26)
Biotechnology (11)
Bladder cancer (43)
Brain cancer (39)
Breast cancer (235)
Cancer (1875)
Cardiovascular disease (126)
Career advice (343)
Career pathing (10)
CAR-T (101)
CDC (23)
Cell therapy (258)
Cervical cancer (16)
Clinical research (20523)
Collaboration (454)
Commercialization (1)
Company closure (1)
Compensation (30)
Complete response letters (8)
COVID-19 (1217)
CRISPR (38)
C-suite (879)
Cystic fibrosis (35)
Data (2957)
Decentralized trials (2)
Denatured (7)
Depression (56)
Dermatology (29)
Diabetes (174)
Diagnostics (1868)
Digital health (11)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (81)
Drug pricing (14)
Drug shortages (5)
Duchenne muscular dystrophy (52)
Earnings (6852)
Editorial (12)
Employer branding (2)
Employer resources (31)
Events (19389)
Executive appointments (748)
FDA (4208)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (530)
Gene editing (75)
Generative AI (6)
Gene therapy (179)
GLP-1 (188)
Government (1024)
Grass and pollen (1)
Guidances (31)
Healthcare (5128)
Hematology (66)
HIV (26)
Huntington's disease (14)
IgA nephropathy (35)
Immunology and inflammation (29)
Immuno-oncology (27)
Indications (38)
Infectious disease (1320)
Inflammatory bowel disease (59)
Inflation Reduction Act (1)
Influenza (42)
Intellectual property (53)
Interviews (41)
IPO (1470)
IRA (8)
Job creations (578)
Job search strategy (317)
JPM (4)
Kidney cancer (9)
Labor market (18)
Layoffs (42)
Leadership (6)
Legal (687)
Licensing (4)
Liver cancer (30)
Longevity (4)
Lung cancer (216)
Lymphoma (166)
Machine learning (15)
Management (9)
Manufacturing (137)
Marketing (1)
MASH (77)
Medical device (3220)
Medtech (3261)
Mergers & acquisitions (1893)
Metabolic disorders (352)
mRNA (65)
Multiple sclerosis (56)
NASH (5)
Neurodegenerative disease (153)
Neuropsychiatric disorders (19)
Neuroscience (1167)
Neurotech (1)
NextGen: Class of 2026 (1798)
Non-profit (1736)
Now hiring (8)
Obesity (96)
Opinion (43)
Ovarian cancer (91)
Pain (62)
Pancreatic cancer (108)
Parkinson's disease (131)
Partnered (6)
Patents (97)
Patient recruitment (253)
Peanut (19)
People (34255)
Phase 1 (6449)
Phase 2 (9370)
Phase 3 (6314)
Pipeline (2259)
Policy (65)
Postmarket research (969)
Preclinical (3246)
Press Release (25)
Prostate cancer (104)
Psychedelics (15)
Radiopharmaceuticals (94)
Rare diseases (278)
Real estate (1293)
Recruiting (17)
Regulatory (3721)
Reports (5)
Research institute (1408)
Resumes & cover letters (23)
Rett syndrome (9)
RNA editing (8)
RSV (11)
Schizophrenia (32)
Series A (74)
Series B (39)
Sickle cell disease (36)
Spinal muscular atrophy (48)
Sponsored (8)
Startups (1132)
Stomach cancer (1)
Supply chain (6)
Tariffs (9)
The Weekly (3)
Vaccines (325)
Venture capital (27)
Weight loss (53)
Women's health (32)
Worklife (3)
Date
Today (3)
Last 7 days (83)
Last 30 days (406)
Last 365 days (6327)
2026 (4059)
2025 (6357)
2024 (7553)
2023 (9314)
2022 (11559)
2021 (13325)
2020 (12827)
2019 (12181)
2018 (9041)
2017 (8769)
2016 (8938)
2015 (10258)
2014 (7820)
2013 (7627)
2012 (7580)
2011 (7575)
2010 (6824)
Location
Africa (265)
Alabama (19)
Alaska (3)
Arizona (80)
Arkansas (6)
Asia (10957)
Australia (2723)
California (3122)
Canada (865)
China (367)
Colorado (132)
Connecticut (121)
Delaware (91)
Europe (29742)
Florida (388)
Georgia (117)
Hawaii (1)
Idaho (13)
Illinois (255)
India (13)
Indiana (129)
Iowa (10)
Japan (156)
Kansas (21)
Kentucky (9)
Louisiana (13)
Maine (19)
Maryland (347)
Massachusetts (2086)
Michigan (64)
Minnesota (146)
Mississippi (4)
Missouri (49)
Montana (6)
Nebraska (6)
Nevada (40)
New Hampshire (12)
New Jersey (795)
New Mexico (10)
New York (853)
North Carolina (467)
North Dakota (3)
Northern California (1704)
Ohio (133)
Oklahoma (9)
Oregon (12)
Pennsylvania (552)
Puerto Rico (5)
Rhode Island (21)
South America (309)
South Carolina (16)
Southern California (1154)
Tennessee (72)
Texas (529)
United States (10829)
Utah (102)
Virginia (81)
Washington D.C. (19)
Washington State (264)
West Virginia (2)
Wisconsin (35)
180,344 Results for "linkoeping university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biosenta Highlights Independent University of Calgary Research Validating Tri-Filler(TM) Antimicrobial Technology
University of Calgary research demonstrates more than 200-fold improvement in antibacterial performance while Biosenta advances commercialization
July 21, 2026
·
5 min read
Layoffs
50 employees impacted as Astellas closes Universal Cells’ Seattle office
By closing the Universal Cells Seattle location, Astellas is reportedly consolidating cell therapy, gene therapy and oncology research at its South San Francisco, California, and Westborough, Massachusetts, sites.
April 14, 2026
·
2 min read
·
Angela Gabriel
Press Releases
AI-Designed Universal Coronavirus Vaccine Clears First Human Trial
July 28, 2026
·
1 min read
Press Releases
Innate Pharma Files Its 2025 Universal Registration Document (Document D’enregistrement Universel) and 2025 Form 20-f Annual Report
April 2, 2026
·
3 min read
Press Releases
Clinilabs Announces New Affiliation With Rutgers University
June 25, 2026
·
3 min read
Press Releases
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
August 20, 2026
·
6 min read
Press Releases
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings
July 20, 2026
·
5 min read
Press Releases
Caris Precision Oncology Alliance Welcomes the University of New Mexico Comprehensive Cancer Center
August 7, 2026
·
8 min read
Press Releases
Nabsys and Indiana University Collaborate to Advance Electronic Genome Mapping Applications in Hematologic Malignancies
August 2, 2026
·
4 min read
Press Releases
Qnovia Secures Worldwide Exclusive License to Novel Antimicrobial Peptide from the University of Virginia
July 29, 2026
·
3 min read
1 of 18,035
Next
